Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Chao Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2473-387X; OpenAlex author ID A5012217069. Sources: OpenAlex.

Their work

Papers
14 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 3 papers · 2018: none · 2019: none · 2020: 1 paper · 2021: 3 papers · 2022: 3 papers · 2023: 1 paper · 2024: 1 paper

Papers 14

  1. Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy. First author DOI 10.1186/s12885-024-12934-y↗
  2. Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective as CT? Co-author DOI 10.1186/s40644-023-00528-z↗
  3. Preoperative Radiomics Approach to Evaluating Tumor-Infiltrating CD8+ T Cells in Patients With Pancreatic Ductal Adenocarcinoma Using Noncontrast Magnetic Reso… Co-author DOI 10.1002/jmri.27871↗
  4. Contrast-enhanced computed tomography radiomics and multilayer perceptron network classifier: an approach for predicting CD20+ B cells in patients with pancrea… Co-author DOI 10.1007/s00261-021-03285-4↗
  5. Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s40644-021-00443-1↗
  6. Noncontrast Magnetic Resonance Radiomics and Multilayer Perceptron Network Classifier: An approach for Predicting Fibroblast Activation Protein Expression in P… Co-author DOI 10.1002/jmri.27648↗
  7. The relationship between microscopic tumor size and CT tumor size in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.clinimag.2020.11.039↗
  8. CT Radiomics and Machine-Learning Models for Predicting Tumor-Stroma Ratio in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.707288↗
  9. Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imaging, and pathologic specimens. Co-author DOI 10.1007/s00261-019-02125-w↗
  10. Effect of region of interest size on ADC measurements in pancreatic adenocarcinoma. Co-author DOI 10.1186/s40644-017-0116-6↗
  11. Optimized ROI size on ADC measurements of normal pancreas, pancreatic cancer and mass-forming chronic pancreatitis. Co-author DOI 10.18632/oncotarget.18457↗
  12. Aberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patients. First author DOI 10.18632/oncotarget.22794↗
  13. Apparent diffusion coefficient (ADC) measurements in pancreatic adenocarcinoma: A preliminary study of the effect of region of interest on ADC values and inter… Co-author DOI 10.1002/jmri.25007↗
  14. Comparison of the Diagnostic Performances of Three Techniques of ROI Placement for ADC Measurements in Pancreatic Adenocarcinoma. First author DOI 10.1016/j.acra.2015.06.017↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianping Lu · 12 shared papers, 2015–2024 · strength 1.46
  2. Yun Bian · 10 shared papers, 2017–2024 · strength 1.35
  3. Chengwei Shao · 9 shared papers, 2017–2024 · strength 1.13
  4. Li Wang · 9 shared papers, 2015–2022 · strength 0.86
  5. Panpan Yang · 4 shared papers, 2017–2024 · strength 0.59
  6. Hui Jiang · 4 shared papers, 2021–2022 · strength 0.52
  7. Yinghao Meng · 4 shared papers, 2021–2022 · strength 0.48
  8. Jieyu Yu · 4 shared papers, 2021–2022 · strength 0.48
  9. Yufei Chen · 2 shared papers, 2023–2024 · strength 0.39
  10. Kai Cao · 3 shared papers, 2021–2022 · strength 0.39
  11. Luguang Chen · 3 shared papers, 2017–2024 · strength 0.34
  12. Jing Li · 2 shared papers, 2021 · strength 0.22
  13. Jun Wang · 1 shared paper, 2023 · strength 0.18
  14. Jianming Zheng · 1 shared paper, 2021 · strength 0.14
  15. Suizhi Gao · 1 shared paper, 2022 · strength 0.14
  16. Shiwei Guo · 1 shared paper, 2022 · strength 0.14
  17. Gang Jin · 1 shared paper, 2022 · strength 0.14
  18. Jianming Zheng · 1 shared paper, 2022 · strength 0.14
  19. Jing Li · 1 shared paper, 2022 · strength 0.13
  20. Li Liu · 2 shared papers, 2015–2016 · strength 0.11
  21. Hao Zhang · 1 shared paper, 2021 · strength 0.11
  22. Qi Li · 1 shared paper, 2021 · strength 0.11
  23. Qi Li · 1 shared paper, 2021 · strength 0.11
  24. Jianping Lu · 1 shared paper, 2017 · strength 0.06
  25. Qiang Hao · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.